Can the form be signed electronically?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and retention are demonstrated.

Do I need a HIPAA BAA for eSignature services?

Yes. When PHI is involved, use a vendor that will sign a Business Associate Agreement (BAA) to meet HIPAA obligations and protect patient data.

What if the patient revokes consent later?

Document revocation in the chart and follow clinical protocols; retain both the original consent and revocation records per retention rules for potential audits.

Who can sign on the patient’s behalf?

A legally authorized representative may sign when permitted by state law; document the representative’s authority and relationship in the form.

Are notarization or witnesses required?

Most jurisdictions do not require notarization for clinical consents; check state-specific rules for witnesses or notarization if the form will be used for other legal purposes.

How long should I keep completed forms?

Follow HIPAA six-year minimum (45 CFR §164.530(j)) and applicable federal standards; retain for longer if state law or payer audits require it.

Electronic Signature
Templates
Healthcare
Healthcare Aflibercept Form

Healthcare Aflibercept Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Aflibercept Consent and Treatment Form

Patient Information

Patient Name:

Date of Birth: Gender: Male Female Other

Address Primary Phone Emergency Contact (Name and Phone)

Insurance Information

Insurance Provider

Policy / ID Number

Group Number

Subscriber Name

Medical History

Current Medications Drug Allergies Prior Eye Surgeries / Procedures

Do you take blood thinners (anticoagulants)? Yes No

If yes, list medication(s)

Are you pregnant or breastfeeding? Yes No

Procedure Details (Aflibercept)

Medication: Aflibercept (intravitreal injection). Eye(s) to be treated: Left Right Both

Planned Dose

Medication Lot / Expiration

Scheduled Procedure Date: Clinician:

Risks, Benefits and Alternatives

I acknowledge that the clinician has explained the intended benefits of intravitreal aflibercept, including reduction of macular edema and stabilization or improvement of vision where appropriate. I understand that multiple injections may be required and that a favorable outcome is not guaranteed.

I understand the significant risks associated with intravitreal injections include, but are not limited to: endophthalmitis (severe intraocular infection) which can result in permanent vision loss; retinal detachment; vitreous hemorrhage; elevated intraocular pressure; corneal abrasion or ulcer; intraocular inflammation; allergic or systemic reactions including stroke or myocardial infarction in rare cases; and transient or permanent decrease in vision. These risks have been explained to me in clear terms.

Alternatives to aflibercept injection were discussed with me, which may include observation, laser therapy, alternative intravitreal medications, corticosteroid therapy, or referral for surgical evaluation. I understand there may be risks associated with these alternatives as well.

Consent and Authorizations

By initialing or checking the boxes below, I acknowledge the following statements are true and that I give informed consent for treatment.

I have been informed of the nature and purpose of the proposed procedure, the anticipated benefits, the material risks, and the alternatives. I have had the opportunity to ask questions and all my questions have been answered to my satisfaction. I understand that repeat injections may be recommended and that discontinuation of treatment may adversely affect my vision. I consent to administration of aflibercept by the clinician named above and such assistants as deemed necessary. I consent to clinical photography/videography for medical records and treatment documentation.

HIPAA Authorization: I authorize the release and use of my protected health information, including records related to this treatment, for purposes of treatment, payment and healthcare operations, including communication with my insurer and other providers involved in my care. This authorization includes release of information necessary to process claims and to provide continuity of care.

Authorization Expiration Date

Withdrawal of Authorization: I understand that I may revoke this authorization at any time by providing written notice, except to the extent that action has already been taken in reliance on this authorization.

Pre-Procedure Instructions / Acknowledgements

I agree to notify the clinic immediately if I develop any signs of infection, fever, cough, or new medical problems prior to my procedure. I will follow pre-procedure instructions provided by clinic staff, including any medication or drop regimen.

Patient Concerns or Questions

Certification

I certify that the information I have provided is complete and accurate to the best of my knowledge. I understand that the clinician and clinical staff will document this consent in my medical record and will record the medication lot and administration details at the time of procedure.

Patient Name:

Relationship to Patient (if signing for patient):

Signature:

Date:

What the Healthcare Aflibercept Form Is and Why It Matters

The Healthcare Aflibercept Form is a clinical and administrative document used to authorize, document, and bill for intravitreal aflibercept (anti-VEGF) administration. It typically records patient identification, clinical indication, prior treatment history, dosing instructions, lot number and expiration, informed consent, ordering provider information (including NPI), and payer authorization details. Clinics use the form to support medical necessity determinations, capture signatures for consent and release, and create an auditable record for the patient chart, pharmacy dispensing, and claims submission.

Core Purposes of the Healthcare Aflibercept Form

The form documents clinical decision-making, records informed consent, and collects payer-required details to reduce claim denials and support compliance.

Who Completes and Signs This Form

Clinical, administrative, and payer stakeholders each interact with the Healthcare Aflibercept Form at different steps.

Ophthalmologist or Retinal Specialist — Orders medication, documents indication and dosing, and obtains clinical informed consent.
Nurse or MA — Verifies identity, records lot/expiration, documents administration time, and completes post-injection instructions.
Billing/Authorization Staff — Submits prior authorization, attaches clinical notes, and confirms payer requirements for reimbursement.

Clear role separation reduces processing delays and supports compliance with clinical and billing requirements.

Step-by-Step: Completing the Form in Clinic

Follow these sequential steps to complete the Healthcare Aflibercept Form from order through documentation.

01

Verify Patient: Confirm identity with two identifiers before any procedure.
02

Record Order: Document indication, dose, and provider NPI in the order section.
03

Obtain Consent: Review risks and alternatives; secure signature and date.
04

Document Administration: Record lot, expiration, time, route, and administering clinician.

How to Set Up an Online Aflibercept Form Workflow

Configure a digital workflow that mirrors clinic processes: order, authorization, consent, administration record, and archive.

Field	Configuration
Upload Format	Accept PDF and DOCX for template and archival compatibility
Auto-fill Fields	Enable patient demographics via EHR integration to reduce manual entry
Conditional Fields	Show insurer-specific fields when payer is selected
Authentication	Require provider authentication (SSO or 2FA) before signing

Where the Completed Form Goes and Who Receives It

After completion, route copies to clinical, pharmacy, and payer endpoints to support care coordination and reimbursement.

Patient Chart: Store the signed form in the EHR encounter record.
Pharmacy or Infusion Pharmacy: Send medication details and lot number for dispensing records.
Billing Team: Attach form to the claim and prior authorization package.
Payer: Transmit authorization documents per payer submission rules.

Essential Information and Required Fields

Patient Name: Full legal name

DOB: MM/DD/YYYY

Provider NPI: Ten-digit NPI

Medication Lot: Lot number and expiry

Clinical Indication: Diagnosis or reason

Consent Signature: Signature and date

Common Mistakes to Avoid When Preparing the Form

Incomplete payer information causes prior authorization delays and potential claim denial; include plan name, ID, and authorization number when available.
Omitting lot number or expiration undermines pharmacovigilance and can complicate recalls or adverse-event investigations.
Using inconsistent patient identifiers across the form and EHR increases the risk of misfiled records and billing rejections.
Missing provider NPI or credential data commonly leads to claim processing errors and payment delays from payers.

Risks and Consequences of Incorrect or Incomplete Forms

Claim Denial: Loss of reimbursement

HIPAA Breach: Civil penalties and remediation

Patient Harm: Clinical risk from incorrect dosing

Inventory Error: Traceability gaps for lots

Authorization Delay: Treatment postponement

Audit Exposure: Documentation deficiencies flagged

Comparing eSignature Options for Healthcare Aflibercept Forms

A concise vendor comparison for common eSignature criteria; signNow is listed first per platform sourcing and available plan tiers.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Typical Processing Timelines and What to Expect

Processing times vary by clinic and payer; plan for internal and external steps when scheduling treatment and follow-up.

Clinic Documentation:

Complete form at visit or within 24–48 hours of administration.

Payer Prior Authorization:

Response times vary; allow several business days to two weeks.

Pharmacy Dispensing:

Verify stock and lot information before same-day administration when possible.

Claims Submission:

Attach completed form to supporting documentation at time of claim.

Audit Response:

Maintain accessible records for at least the first two years for audits.

Frequently Asked Questions About the Healthcare Aflibercept Form

Answers to common operational, legal, and technical questions when preparing, signing, and storing the form.

Need help? Contact support

Can the form be signed electronically?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and retention are demonstrated.
Do I need a HIPAA BAA for eSignature services?
Yes. When PHI is involved, use a vendor that will sign a Business Associate Agreement (BAA) to meet HIPAA obligations and protect patient data.
What if the patient revokes consent later?
Document revocation in the chart and follow clinical protocols; retain both the original consent and revocation records per retention rules for potential audits.
Who can sign on the patient’s behalf?
A legally authorized representative may sign when permitted by state law; document the representative’s authority and relationship in the form.
Are notarization or witnesses required?
Most jurisdictions do not require notarization for clinical consents; check state-specific rules for witnesses or notarization if the form will be used for other legal purposes.
How long should I keep completed forms?
Follow HIPAA six-year minimum (45 CFR §164.530(j)) and applicable federal standards; retain for longer if state law or payer audits require it.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now